Founded in 2013 by entrepreneur Dwayne D’Souza, HeliosX has grown into one of the world’s largest digitally native healthcare networks, spanning nine countries and more than two million customers. The group’s asynchronous telemedicine engine lets patients complete a consultation in minutes; licensed clinicians review each case, and HeliosX’s in-house pharmacies dispense personalised therapies that arrive at the customer’s door within 24-48 hours.  

HeliosX operates a portfolio of category-leading brands—including MedExpress (e-pharmacy and online GP), Dermatica (custom dermatology), Levity (prescription weight-loss), RocketRx (men’s health) and ZipHealth (US telemedicine)—all united by a single technology stack that removes bottlenecks, slashes costs and lifts Net Promoter Scores above 70. Backed by a 500-strong workforce of clinicians, pharmacists, engineers and data scientists, the company processed 8.4 million orders in 2024 while maintaining strict clinical governance and MHRA/FDA compliance.